Edwards Lifesciences CEO Bernard Zovighian [Photo courtesy of Edwards Lifesciences]
Edwards Lifesciences is the world’s 24th-largest medical device company, according to our 2025 Medtech Big 100 ranking by revenue. That ranking was based on the structural heart device developer and manufacturer’s 2024 revenue of $5.4 billion. The company reported $6.1 billion in revenue for 2025, up 11.5% from the year before.
Recruiting and retaining top talent — both at the executive and engineering level — is crucial in the medtech industry, but employee compensation is kept secret in most cases. Medical Design & Outsourcing tracks and analyzes these pay figures when disclosed by major device developers and manufacturers.
MDO Min-Vasive Medtech Special Report: Interviews and audience Q&As with minimally invasive engineers from Edwards Lifesciences, Jupiter Endo and Compremium
Edwards Lifesciences executive pay
The U.S. Securities and Exchange Commission requires publicly held companies to disclose total compensation for their CEO, CFO and three of the highest-paid executives.
Edwards Lifesciences CEO Bernard Zovighian received $17.5 million in total compensation for 2025, up 19% from $14.5 the year before.
Zovighian’s compensation included a $1.2 million salary, $7.1 million in stock awards, $6.5 million in option awards, a $2.4 million cash performance bonus and $189,085 in other compensation.
His other compensation included $114,406 in Edwards’ executive deferred compensation plan (EDCP) matching contributions, $17,500 in 401(k) matching contributions, home and personal security worth $56,015 and $1,164 in other perks.
Previously: What Edwards Lifesciences CEO Bernard Zovighian learned from Mike Mussallem
Edwards Lifesciences Corporate VP and CFO Scott Ullem [Photo courtesy of Edwards Lifesciences]
Ullem’s compensation included an $807,898 salary, $2.2 million in stock awards, $2 million in option awards, a $966,435 cash performance bonus and $71,257 in other compensation.
His other compensation included $48,993 in EDCP matching contributions, $17,500 in 401(k) matching contributions and $4,764 in other perquisites.
Ullem will step down as CFO at the end of May but will work with the company on a reduced schedule as a strategic advisor until June 30, 2028. Theodora “Doretta” Mistras, a former pharmaceutical company CFO, will succeed Ullem.
Former Edwards Lifesciences Corporate VP and Transcatheter Aortic Valve Replacement and Surgical Structural Heart Group President Larry Wood [Photo courtesy of Edwards Lifesciences]
Wood resigned on Sept. 1, 2025, to become CEO of Procept BioRobotics. After leaving the company as an executive, Wood entered into a consulting agreement with Edwards through December 31, 2027.
Wood’s compensation included a $635,919 salary, $1.8 million in stock awards, $1.6 million in option awards, a $689,382 cash performance bonus and $61,829 in other compensation.
His other compensation included $43,068 in EDCP matching contributions, $17,500 in 401(k) matching contributions and $1,261 in other perquisites.
Edwards Lifesciences Corporate VP of Transcatheter Mitral and Tricuspid Therapies, and Surgical and Implantable Heart Failure Management Daveen Chopra [Photo courtesy of Edwards Lifesciences]
Chopra’s compensation included a $671,042 salary, $1.8 million in stock awards, $1.4 million in option awards, an $824,239 cash performance bonus and $60,611 in other compensation.
His other compensation included $40,849 in EDCP matching contributions, $17,500 in 401(k) matching contributions and $2,262 in other perquisites.
Edwards Lifesciences Corporate VP of Strategy and Corporate Development Donald Bobo received $4.2 million in total compensation for 2025, up 13% from $3.7 million the year before.
Edwards Lifesciences Corporate VP of Strategy and Corporate Development Donald Bobo [Photo courtesy of Edwards Lifesciences]
His other compensation included $26,699 in EDCP matching contributions, $17,500 in 401(k) matching contributions and $4,381 in other perquisites.
Edwards Lifesciences Corporate VP of Europe, Middle East, Africa, Canada and Latin America (EMEACLA) Annette Brüls received $3.7 million in total compensation for 2025.
Brüls’ compensation was paid in Swiss Francs, but Edwards converted its reported values to U.S. dollars using an exchange ratio of 1.2088 USD, which the company said was its average monthly intercompany Swiss Franc to U.S. dollar exchange rate for 2025.
Edwards Lifesciences Corporate VP of Europe, Middle East, Africa, Canada and Latin America (EMEACLA) Annette Brüls [Photo courtesy of Edwards Lifesciences]
She participates in the company’s pension plan for salaried employees at its Nyon, Switzerland, facility. None of Edwards’ other named executives participates in a company pension plan.
Brüls’ other compensation includes $150,330 in pension plan matching contributions and $31,376 in company car payments.
“Our compensation programs are designed to attract, retain, motivate and engage executives with superior leadership and management capabilities to enhance stockholder value,” the company said in the filing.
Edwards Lifesciences median worker pay and CEO pay ratio
The U.S. Securities and Exchange Commission requires publicly traded companies to calculate the gap between CEO compensation and pay for its median employee.
Edwards Lifesciences calculated its median employee wage at $89,827, up 21% from $74,125 the year before.
The latest median employee pay figure put Edwards Lifesciences’ CEO pay at 194 times more than its median employee’s pay in 2025. That pay gap narrowed for the second consecutive year and from 197:1 the year before.
At other medtech companies that offer more details about their median workers than required by the SEC pay disclosure rules, those median medtech workers often hold technical roles such as device design or engineering.
Edwards Lifesciences shareholders overwhelmingly voted in support of the company’s executive compensation practices at its May 7 annual meeting.
More medtech compensation analysis for CEOs, top-paid executives and median workers
- Zimmer Biomet discloses executive pay and double-digit increase for its median employee
- Siemens Healthineers CEO and HR leader got double-digit pay increases
- Alcon increases executive comp budget to close ‘transatlantic pay gap’
- Accendra Health (formerly Owens & Minor) discloses executive pay
- Baxter discloses executive pay under new CEO and golden parachute for the last CEO
- Stryker pay drops for top executives and the median employee
- Henry Schein discloses exec pay for longtime CEO Stan Bergman’s final year
- Abbott’s device leader pay climbs again with double-digit sales growth
- Medtech CDMO Integer discloses executive pay after new CEO steps in
- Cardinal Health reported a big increase in median worker pay
- GE HeathCare discloses CEO pay decrease but increases for other execs and the median employee
- BD reports lower CEO pay but increases for other execs and the median worker
- Johnson & Johnson discloses executive pay, denies them a talc fight ‘windfall’
- Boston Scientific CEO pay rises again along with median employee pay
- Intuitive discloses CEO pay with new leader at the helm
- Medtronic discloses pay for Diabetes leaders ahead of MiniMed IPO
